文章核心观点 公司公布主要内幕交易情况并提供联系方式 [1] 分组1 - 公司公布主要内幕交易情况，详情见附件通知 [1] - 如需进一步信息可联系首席财务官Kristian Flaten，电话+47 95092322，邮箱ir@idexbiometrics.com [1] - 该信息需遵循欧盟市场滥用法规第19条和挪威证券交易法第5 - 12条的披露要求 [1] 分组2 - 附件包含2025年6月11日Marc O Polo、Dobber Corporation、K Konsult、Elgin的通知 [2]

文章核心观点 公司董事会决定将股份合并生效日期（及公司股票相关国际证券识别编码变更日期）从2025年6月11日推迟至2025年6月20日，以便在实施股份合并前完成后续发行 [1][2] 股份合并相关 - 2025年4月11日公司临时股东大会决议股份合并及国际证券识别编码变更，原股份合并生效日期为2025年6月11日或董事会确定的更晚日期 [1] - 因技术原因董事会希望在实施股份合并前完成后续发行，故将股份合并生效日期（及公司股票相关国际证券识别编码变更日期）推迟至2025年6月20日 [2] 后续发行相关 - 临时股东大会决议的后续发行正在进行，且在2025年6月11日前不会完成 [2] 公司信息 - IDEX Biometrics ASA是指纹生物识别领域的全球技术领导者，提供支付、访问控制和数字身份验证解决方案，基于专利和专有传感器技术、集成电路设计和软件，其生物识别解决方案针对基于卡片的支付和数字认证应用，与领先的卡片制造商和科技公司合作将解决方案推向市场 [3]

Reference is made to the stock exchange notice from IDEX Biometrics ASA (the “Company”) on 11 April 2025 regarding key information relating to share consolidation and change of ISIN as resolved by the 11 April 2025 Extraordinary General Meeting in the Company (the “EGM”). The effective date of the share consolidation was stated to be 11 June 2025 or such later date as determined by the board of directors of the Company (the “Board”). Reference is also made to the subsequent offering resolved by the EGM (the ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice from IDEX Biometrics ASA (the "Company") on 21 May 2025 regarding the commencement of the subscription period (the "Subscription P ...

The annual general meeting of IDEX Biometrics ASA on 21 May 2025 resolved that the board members could elect to receive all or part of the board remuneration in the form of shares in IDEX; that the number of shares shall correspond to a value of 133 per cent of the NOK amount of board remuneration taken in shares; that the board member must pay a subscription price per share equal to the par value of the share, being NOK 0.01. One board member took part of the board remuneration in shares, and 5,412,932 ne ...

文章核心观点 - 2025年5月21日IDEX Biometrics ASA举行年度股东大会，所有决议按会议通知和议程更新提案通过，会议记录将适时在公司网站公布 [1] 公司信息 - IDEX Biometrics ASA是指纹生物识别领域全球技术领先者，提供支付、访问控制和数字身份认证解决方案，基于专利和专有传感器技术、集成电路设计和软件，目标是基于卡片的支付和数字认证应用，与领先卡片制造商和科技公司合作将解决方案推向市场 [1] 会议信息 - 会议于2025年5月21日举行，所有决议按提案通过，会议记录将在公司网站www.idexbiometrics.com公布 [1] 联系方式 - 如需进一步信息可联系首席财务官Kristian Flaten，电话+47 95092322，邮箱ir@idexbiometrics.com [1] 通知信息 - 本通知由首席财务官Kristian Flaten于2025年5月21日14:45 CET代表公司发布，信息需遵守挪威证券交易法第5 - 12条披露要求 [1]

In connection with the first quarter 2025 report released earlier today, IDEX Biometrics CEO Anders Storbråten will host a presentation at Arctic Securities at 12:00 CET today. The presentation is attached. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@idexbiometrics.com About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital ide ...

IDEX Biometrics ASA's first quarter 2025 report is attached to this notice. Recent highlights: On 11 March 2025 IDEX Biometrics announced a new strategy with a fundamental shift in how the company would take its unique technology and products to market New CEO appointed – Anders Storbråten Securing a new debt facility of NOK 30 million, converted to shares Heights convertible bond renegotiated and amended Range of operational improvement initiatives under way – target quarterly run rate OPEX from end Q3 202 ...

Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion” and “Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription ...

The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The full text of the Nomination Committee's proposal to the 2025 Annual General Meeting in IDEX Biometrics ASA is enclosed. For further information, please contact: Kristian Flaten, CFO, Tel: +47 950 ...